MUC1 and pneumonitis: Five patients (17%) discontinued adjuvant chemotherapy after one cycle due to patient preference (n = 3), adverse event (AE) (n = 1) (elevation of Krebs von den Lungen‐6 [KL‐6] serum levels without pneumonitis), and progressive disease (n = 1).